Personalized Translational Platform for Biomarker Discovery in Brain Tumors

NCT01240161 · clinicaltrials.gov ↗

COMPLETED

Status

37

Enrollment

OTHER

Sponsor class

Conditions

High Grade Glioma

Interventions

DRUG: FLT-PET/CT: (3'deoxy-3'-[(18)F] fluorothymidine) PET/CT

Sponsor

Marcelo F. Di Carli, MD, FACC

Collaborators

[object Object]
[object Object]